Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikki Jahnke

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Cochrane Database of Systematic Reviews|October 2, 2015
Newborn screening for homocystinuriaJohn H Walter, Nikki Jahnke, Tracey Remmington
The Cochrane Database of Systematic Reviews|September 5, 2019
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisJayesh Bhatt, Nikki Jahnke, Alan R Smyth
Paediatric Respiratory Reviews|December 12, 2012
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosisGerard Ryan, Nikki Jahnke, Tracey Remmington, et al.
The Cochrane Database of Systematic Reviews|June 11, 2020
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisSherie Smith, Valerie Waters, Nikki Jahnke, et al.
Paediatric Respiratory Reviews|June 2, 2017
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha Aslam, Nikki Jahnke, Tracey Remmington, et al.
The Cochrane Database of Systematic Reviews|December 10, 2025
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosisRebecca Calthorpe, Sherie Smith, Nikki Jahnke, et al.
Paediatric Respiratory Reviews|July 16, 2013
20 years of Cochrane Glancing backwards - moving ahead: a tale of two Cochrane review groupsEmma Welsh, Nikki Jahnke, Tracey Remmington, et al.
The Cochrane Database of Systematic Reviews|May 7, 2026
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Matthew Heneghan, Sherie Smith, Nikki Jahnke, et al.
The Cochrane Database of Systematic Reviews|January 20, 2025
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosisMatthew N Hurley, Sherie Smith, Patrick Flume, et al.
The Cochrane Database of Systematic Reviews|March 27, 2025
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosisNikki Jahnke, Valerie Waters, Felix Ratjen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Cochrane Database of Systematic Reviews|October 2, 2015
Newborn screening for homocystinuriaJohn H Walter, Nikki Jahnke, Tracey Remmington
The Cochrane Database of Systematic Reviews|September 5, 2019
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisJayesh Bhatt, Nikki Jahnke, Alan R Smyth
Paediatric Respiratory Reviews|December 12, 2012
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosisGerard Ryan, Nikki Jahnke, Tracey Remmington, et al.
The Cochrane Database of Systematic Reviews|June 11, 2020
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisSherie Smith, Valerie Waters, Nikki Jahnke, et al.
Paediatric Respiratory Reviews|June 2, 2017
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha Aslam, Nikki Jahnke, Tracey Remmington, et al.
The Cochrane Database of Systematic Reviews|December 10, 2025
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosisRebecca Calthorpe, Sherie Smith, Nikki Jahnke, et al.
Paediatric Respiratory Reviews|July 16, 2013
20 years of Cochrane Glancing backwards - moving ahead: a tale of two Cochrane review groupsEmma Welsh, Nikki Jahnke, Tracey Remmington, et al.
The Cochrane Database of Systematic Reviews|May 7, 2026
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Matthew Heneghan, Sherie Smith, Nikki Jahnke, et al.
The Cochrane Database of Systematic Reviews|January 20, 2025
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosisMatthew N Hurley, Sherie Smith, Patrick Flume, et al.
The Cochrane Database of Systematic Reviews|March 27, 2025
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosisNikki Jahnke, Valerie Waters, Felix Ratjen, et al.
Pageof 3